Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-09
DOI
10.1186/s13287-020-02122-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results
- (2020) Emin ÖZMERT et al. Stem Cell Research & Therapy
- Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results
- (2020) Emin Özmert et al. Stem Cell Research & Therapy
- Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration
- (2020) Ricardo Usategui-Martín et al. Molecular Therapy-Methods & Clinical Development
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
- (2019) Aleksandra Musiał-Wysocka et al. CELL TRANSPLANTATION
- Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles
- (2019) Kyong-Su Park et al. Stem Cell Research & Therapy
- Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy
- (2019) Vladimir Holan et al. World Journal of Stem Cells
- Osteoinductive Material to Fine-Tune Paracrine Crosstalk of Mesenchymal Stem Cells With Endothelial Cells and Osteoblasts
- (2019) Hassan Rammal et al. Frontiers in Bioengineering and Biotechnology
- Non-syndromic retinitis pigmentosa
- (2018) Sanne K. Verbakel et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Progress of stem/progenitor cell-based therapy for retinal degeneration
- (2017) Zhimin Tang et al. Journal of Translational Medicine
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients
- (2017) Yong Liu et al. Stem Cell Research & Therapy
- Retinal fibrosis in diabetic retinopathy
- (2016) Sayon Roy et al. EXPERIMENTAL EYE RESEARCH
- Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology
- (2016) Mitsuru Sawa JAPANESE JOURNAL OF OPHTHALMOLOGY
- Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)
- (2015) Rubens C Siqueira et al. Stem Cell Research & Therapy
- Intravitreal Autologous Bone Marrow CD34+ Cell Therapy for Ischemic and Degenerative Retinal Disorders: Preliminary Phase 1 Clinical Trial Findings
- (2014) S. S. Park et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Embryonic stem cell trials for macular degeneration: a preliminary report
- (2012) Steven D Schwartz et al. LANCET
- Clinical Evidence of Sustained Chronic Inflammatory Reaction in Retinitis Pigmentosa
- (2012) Noriko Yoshida et al. OPHTHALMOLOGY
- Retinitis Pigmentosa: Genes and Disease Mechanisms
- (2011) Francesco Parmeggiani et al. CURRENT GENOMICS
- INTRAVITREAL INJECTION OF AUTOLOGOUS BONE MARROW–DERIVED MONONUCLEAR CELLS FOR HEREDITARY RETINAL DYSTROPHY
- (2011) Rubens C Siqueira et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The Role of Mouse Mesenchymal Stem Cells in Differentiation of Naive T-Cells into Anti-Inflammatory Regulatory T-Cell or Proinflammatory Helper T-Cell 17 Population
- (2011) Eliska Svobodova et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started